[1]CurrentPatentAssignee:KTBTUMORFORSCHUNGSGMBH-WO2004/83223,2004,A1Locationinpatent:Page/Pagecolumn11-12
[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2015/95301,2015,A2Locationinpatent:Page/Pagecolumn131;132
[2]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2016/203432,2016,A1Locationinpatent:Paragraph00541
[1]Renault,Kévin;Jouanno,Laurie-Anne;Lizzul-Jurse,Antoine;Renard,Pierre-Yves;Sabot,Cyrille[Chemistry-AEuropeanJournal,2016,vol.22,#51,p.18522-18531]
[1]Renault,Kévin;Jouanno,Laurie-Anne;Lizzul-Jurse,Antoine;Renard,Pierre-Yves;Sabot,Cyrille[Chemistry-AEuropeanJournal,2016,vol.22,#51,p.18522-18531]
[1]Renault,Kévin;Jouanno,Laurie-Anne;Lizzul-Jurse,Antoine;Renard,Pierre-Yves;Sabot,Cyrille[Chemistry-AEuropeanJournal,2016,vol.22,#51,p.18522-18531]
Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.